Company Monitoring Page for Janssen

latest headlines for company on cafepharma

Milestone payment triggers Genmab guidance increase
Yahoo/Reuters
Tue, 11/26/13 - 09:00 am
Tags:
Genmab, daratumumab, JNJ, Janssen
Vertex Gains on Sale of Drug Rights to Johnson & Johnson Unit
Barron's
Wed, 11/20/13 - 04:37 pm
Tags:
Vertex Pharmaceuticals, JNJ, Incivo, Janssen, hepatitis C
J&J shares are helped by findings on stroke-prevention medication
Marketwatch
Wed, 11/20/13 - 08:41 am
Tags:
JNJ, Xarelto, Janssen
J&J’s Janssen Loses $11 Million Jury Verdict Over Topamax
Bloomberg
Tue, 11/19/13 - 07:38 am
Tags:
Janssen, JNJ, Topamax, birth defects
Janssen Pleads Guilty to Selling Risperdal Off-Label
Bloomberg
Fri, 11/8/13 - 10:51 am
Tags:
Janssen, off-label, Risperdal, JNJ
Janssen Faces 2nd Trial Over Drug’s Link to Birth Defects
Bloomberg
Wed, 10/30/13 - 10:12 am
Tags:
Janssen, birth defects, Topamax
Janssen's Topamax Users Blame Drug for Birth Defects
Bloomberg
Tue, 10/15/13 - 04:58 pm
Tags:
Janssen, Topamax, JNJ, birth defects
Janssen Purchase Doesn't Change Case For Idenix
Seeking Alpha
Thu, 10/10/13 - 06:17 pm
Tags:
Janssen, Idenix, IDX719
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wed, 09/18/13 - 10:27 am
Tags:
rheumatoid arthritis, Humira, AbbVie, Enbrel, Amgen, Remicade, Janssen, Celebrex, Pfizer, Bristol-Myers Squibb, Orencia, Cimza, UCB, Simponi, JNJ, Arthrotec, Vimovo, AstraZeneca, Kineret
FDA grants priority review to blood cancer treatment from Pharmacyclics
Yahoo/AP
Thu, 08/29/13 - 09:07 am
Tags:
FDA, Pharmacyclics, Janssen, JNJ, ibrutinib, mantle cell lymphoma, chronic lymphocytic leukemia
J&J hunts for dengue fever drugs in tie-up with academia
Reuters
Thu, 08/29/13 - 09:05 am
Tags:
J&J, dengue, Janssen
Inside HCV: An Interview with Janssen
Motley Fool
Thu, 06/13/13 - 10:54 am
Tags:
hepatitis C, Janssen, Gilead, JNJ, Vertex, simeprevir, sofosbuvir
Second Genome announces agreement with Janssen
Yahoo/Fly on the Wall
Wed, 06/5/13 - 12:27 pm
Tags:
Janssen, Second Genome
J&J releases more Doxil to the market
Fierce Pharma
Tue, 04/9/13 - 02:49 pm
Tags:
JNJ, Doxil, cancer, chemotherapy, Janssen
Drug maker JNJ: $327M deceptive marketing penalty should be invalidated because no one in SC hurt
Yahoo/AP
Fri, 03/22/13 - 10:40 am
Tags:
JNJ, Janssen, South Carolina
Janssen submits NDA to FDA for canagliflozin/metformin
Yahoo/Fly on the Wall
Wed, 12/12/12 - 10:01 am
Tags:
Janssen, FDA, canagliflozin, diabetes, metformin
Vertex to collaborate with Janssen on Phase 2 all-oral study for hepatitis C
The Fly on the Wall
Thu, 11/1/12 - 10:05 am
Tags:
Vertex, Janssen, hepatitis C, simeprevir, VX-135
Mylan Launches Generic Version of Sporanox® Capsules By Mylan Inc.
Sacramento Bee, CA
Sun, 07/29/12 - 12:58 pm
Tags:
Mylan, Sporanox, generics, Janssen, blatsomycosis, histoplasmosis, aspergillosis
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:12 pm
Tags:
Xenon, Virobay, Tolero Pharmaceuticals, Threshold Pharmaceuticals, Novartis, Merck KGaA, Merck, MannKind, licensing, Janssen, Isis Pharmaceuticals, Ironwood, Inhibrx Thrombogenics, GSK, Genmab, Genentech, Galapagos, Forma Therapeutics, Endocyte, Endo, Enanta, Celgene, Bristol-Myers Squibb, Boehringer Ingelheim, Bionomics, Biogen Idec, BioDelivery Sciences, AstraZeneca, Angiochem, AC Immune, Abbott Laboratories, LEO Pharma
J&J seeks OK for first drug against resistant TB
Yahoo/AP
Mon, 07/2/12 - 12:25 pm
Tags:
JNJ, tuberculosis, bedaquiline, Janssen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.